Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.

Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA.

Open source

DOI: 10.1002/cncr.70610
Published: 2026-10-01
Container: Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70610,
  title = {Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.},
  author = {Evageliou NF and  Renfro LA and  Vallance KL and  Varela CR and  Benedetti DJ and  Cost NG and  Ehrlich PF and  Kalapurakal JA and  Khanna G and  Aldrink JH and  Glick RD and  Ortiz MV and  Parsons LN and  Paulino AC and  Artunduaga M and  Smith EA and  Dix DB and  Fernandez CV and  Dome JS and  Geller JI and  Mullen EA.},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70610},
  url = {https://doi.org/10.1002/cncr.70610}
}

RIS

TY  - JOUR
TI  - Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.
AU  - Evageliou NF
AU  -  Renfro LA
AU  -  Vallance KL
AU  -  Varela CR
AU  -  Benedetti DJ
AU  -  Cost NG
AU  -  Ehrlich PF
AU  -  Kalapurakal JA
AU  -  Khanna G
AU  -  Aldrink JH
AU  -  Glick RD
AU  -  Ortiz MV
AU  -  Parsons LN
AU  -  Paulino AC
AU  -  Artunduaga M
AU  -  Smith EA
AU  -  Dix DB
AU  -  Fernandez CV
AU  -  Dome JS
AU  -  Geller JI
AU  -  Mullen EA.
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70610
UR  - https://doi.org/10.1002/cncr.70610
ER  -

APA

NF, E., LA, R., KL, V., CR, V., DJ, B., NG, C., PF, E., JA, K., G, K., JH, A., RD, G., MV, O., LN, P., AC, P., M, A., EA, S., DB, D., CV, F., JS, D., JI, G., & EA., M. (2026). Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.. Cancer. https://doi.org/10.1002/cncr.70610

Source records

europe-pmc · retrieved 2026-09-25T06:13:46.303Z